Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04606524
Other study ID # 8-2020
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date October 2020
Est. completion date December 2021

Study information

Verified date October 2020
Source October 6 University
Contact amira abdelwhab
Phone 01007647877
Email amira.abdelwhab.dent@o6u.edu.eg
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

50 females will be included in this study. they will be divided into 2 groups (study group which will include 25 postmenopausal females - and control group which will include premenopausal females) For testing gustatory function, a whole mouth above threshold taste test will be carried out in which a concentration of sucrose, sodium chloride, citric acid and quinine hydrochloride solutions were used for sweet, salty, sour and bitter types of taste respectively . Saliva will be collected to evaluate MUC1 expression


Description:

50 females will be included in this study. they will be divided into 2 groups (study group which will include 25 postmenopausal females - and control group which will include premenopausal females) For testing gustatory function, a whole mouth above threshold taste test will be carried out in which a concentration of sucrose, sodium chloride, citric acid and quinine hydrochloride solutions were used for sweet, salty, sour and bitter types of taste respectively . Five concentration levels (in ½ log steps) of sodium chloride (0.01-1.0 mM), citric acid (0.32-0.032 mol l-1), quinine hydrochloride (0.01- 1.0 mM) and sucrose (0.01-1.0 mM) will be prepared in 5 ml samples. All the solutions will be made with distilled water. The intensity threshold of taste perception of each solution will be determined by scoring the lowest concentration as 5' and the highest concentration as 1'. The solutions will be given in increasing concentrations. The patient then should identify the quality (salty, sour, sweet, bitter or tasteless) and intensity of each test solution . Quality judgments for each solution will be coded as correct, incorrect or tasteless by asking subjects to name the taste they perceived. Saliva will be collected in the morning between 9:00 am and 11:00 am. Patient will be instructed to stop eating and drinking at least 2 h before sample collection. Chewing 1 g of gum base will be used to stimulate salivary flow. The saliva that will be collected for the first 2 min will be discarded, and then Stimulated whole saliva will be collected for the next 10 min with the mechanical chewing stimulation. Two milliliters of Stimulated whole saliva from each participant will be collected and added to RNA stabilizing solution and used for RNA extraction. The SWS samples will be centrifuged at 10,000 g for 20 min at 48C to remove any cellular debris. The clarified supernatants will be aliquoted and frozen at 70 C for analytic experiments. this is to determination of oral mucosal epithelial MUC1 expression level


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 50
Est. completion date December 2021
Est. primary completion date October 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 20 Years to 65 Years
Eligibility Inclusion Criteria: Inclusion criteria for study group include individuals who are in the age range of 50-75 years, history of complete amenorrhoea patients who are not taking any medication [including hormone replacement therapy (HRT) for female patients]. Also females who are not a denture wearer and those who are having good oral hygiene. Inclusion criteria for study group include individuals who are in the range between 20-40 years with normal menstrual cycle of 28 to 30 days. they should be healthy volunteers free from any systemic diseases Exclusion Criteria: - Exclusion criteria for both groups include patients having any oral diseases (like oral candidiasis) - those who have any systemic diseases (such as diabetes, nutritional de?ciency, cardiovascular, respiratory and endocrinal disorders). - Also any history that could a?ect gustatory function (e.g medications &radiotherapy or smoking

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
October 6 University

Outcome

Type Measure Description Time frame Safety issue
Primary Alterations of the gustatory function in postmenopausal females , a whole mouth above threshold taste test will be carried out in which a concentration of sucrose, sodium chloride, citric acid and quinine hydrochloride solutions were used for sweet, salty, sour and bitter types of taste respectively 12-18 month
Secondary MUC1 expression Two milliliters of Stimulated whole saliva from each participant will be collected and added to RNA stabilizing solution and used for RNA extraction 12-18 month
See also
  Status Clinical Trial Phase
Completed NCT04248374 - Fatty Acid Taste Rating With or Without Sour Taste Adaptation N/A
Completed NCT05518825 - Assessment of ONS-flavour Preference in Cancer Patients With and Without Taste Alterations N/A
Completed NCT04263415 - The Effects of Semaglutide on Taste, Tongue Tissue Transcriptome, Gastric Emptying and Central Neural Response in Women With PCOS and Obesity Phase 4
Completed NCT05819073 - Astringency and Oral Health N/A
Completed NCT03548038 - Taste Changes With Bariatric Surgery
Completed NCT04107688 - Taste Perception, Salivary Proteins & the Oral Microbiome N/A
Completed NCT03501238 - Interaction of Salivary Proteins and Polyphenols N/A
Withdrawn NCT02617576 - Flavoring Oral Contrast for MR Enterography N/A
Completed NCT03824925 - Efficacy of Zinc on Concurrent Chemo-radiotherapy Induced Taste Alterations Phase 3
Completed NCT06089993 - Impact of Acute Resistance Exercise on Taste Perception and Appetite Response to Plant Protein in Resistance Trained Adults N/A
Recruiting NCT06287294 - An Investigation Into Taste Problems Associated With Xerostomia in Patients With Advanced Cancer
Completed NCT04629560 - Miracle Fruit Powder for the Treatment of Taste Alterations Secondary to Chemotherapy Early Phase 1
Not yet recruiting NCT04038281 - Genetics of Bitter and Fat Taste
Recruiting NCT06384365 - Interaction of Inflammation, Taste Perception and Preferences as a Function of Physical Activity and Body Composition